Followers | 3819 |
Posts | 239727 |
Boards Moderated | 0 |
Alias Born | 07/30/2007 |
Monday, August 24, 2020 10:12:09 AM
TEAM UDAYAVANI, AUG 15, 2020, 1:19 PM Doctors at a Hospital in US have used a new drug called RLF-100, also known as aviptadil, that has led to rapid recovery from respiratory failure in critically ill Covid-19 patients
The drug has been approved by the FDA for emergency use and Houston Methodist Hospital was the first to report the rapid recovery of patients on ventilators and those with severe medical conditions
However, doctors in Mumbai have began prescribing the drugs but it is still not available in Inida
Aviptadil
Aviptadil is a formulation of synthetic human Vasoactive Intestinal Peptide (VIP). Vasoactive Intestinal Polypeptide (VIP) was first discovered by the late Dr. Sami Said in 1970.
VIP is known to target the VPAC1 receptor of the ATII cell and to protect that cell against all manner of injuries, including smoke inhalation, exposure to stomach acid, and exposure to infectious agents.
It helps improve muscle activity and blood flow in gastrointestinal tract. VIP has anti-inflammatory and anti-cytokine activity properties.
NeuroRx and Relief Therapeutics have partnered to develop the drug.
According to the report, a 54-year-old man who contracted Covid-19 while being treated for rejection of a double lung transplant came off a ventilator within four days.
The drug appeared to have rapidly cleared pneumonitis findings on an X-ray, improved blood oxygen and a 50 per cent or greater average decrease in laboratory markers associated with Covid-19 inflammation
https://www.udayavani.com/english-news/aviptadil-all-you-need-to-know-about-the-1970-drug-used-for-covid-19-treatment
PickleJar Debuts Nationwide Contest With Brian Kelley for Fans to Win a Three-Day Bahama Cruise • NREG • Jun 3, 2024 8:45 AM
ILUS Provides an Update on the Binding Term Sheet Signed with Actelis Networks (NASDAQ: ASNS) • ILUS • May 31, 2024 12:52 PM
Element79 Gold To Provide Summary and Update on Active Exploration Program, Community Relations at RMEC on June 4 • ELEM • May 30, 2024 1:18 PM
Branded Legacy Secures Exclusive Extraction Partnership with One of the World's Largest Kava Distributors and Producers • BLEG • May 30, 2024 8:30 AM
ECGI Holdings, Inc. Announces $2 Million Debt-to-Equity Conversion • ECGI • May 30, 2024 8:30 AM
North Bay Resources Reports Assays up to >25% Mg, 0.1% Ni, 0.1% Cu, 0.01% Co, 0.3 ppm Pt at Tulameen Platinum Project, British Columbia • NBRI • May 29, 2024 9:03 AM